Efficacy of levocetirizine in perennial allergic rhinitis (PAR) as measured by the number of comfortable days Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Comfortable days and impairment-free days in allergic rhinitis (AR) patients treated with cetirizine and pseudoephedrine combination (CTZ+PSE) Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Rhinitis quality of life (RQOL) in patients with asthma and rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 119s Year: 2002
A comparison of the efficacy of beclomethasone dipropionate (BDP) and fluticasone propionate (FP) aqueous nasal spray on symptoms and quality of life in perennial allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 110s Year: 2003
Cutpoints of the ´control of allergic rhinitis and asthma test´ (CARAT) subscales Source: International Congress 2016 – Asthma management in primary care Year: 2016
Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Combination of montelukast and loratadine provides added benefit for relief of symptoms of seasonal allergic rhinitis (SAR) Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Effects of Omalizumab treatment on nasal symptoms (SNOT score) in patients treated for severe asthma. Source: International Congress 2017 – Asthma management Year: 2017
Early treatment of perennial rhinitis with budesonide or cetirizine: effect on nasal inflammation Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002
Comparison of fluticasone propionate + salmeterol (FP+S) and montelukast (MK) on bronchial reactivity (BR), pulmonary function (PF) and clinical outcome in children with mild asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Clinical effect of clean air administered directly to the breathing zone (airsonett airshower®) on perennial allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007
Effect of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) on risk of severe exacerbations in asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Comparative effects of triamcinolone acetonide aqueous nasal spray (TAA) versus cetirizine (CZ) in seasonal allergic rhinitis (SAR) Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Is the asthma control questionnaire (ACQ) usefull during acute moderate to severe (AMS) asthma exacerbations (AE)? Source: Eur Respir J 2004; 24: Suppl. 48, 591s Year: 2004
Rhinoconjunctivitis quality of life (RCQOL) in allergic rhinitis & its impact on childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 255s Year: 2006
Dyspnoea perception during clinical remission of atopic asthma Source: Eur Respir J 2002; 19: 1047-1050 Year: 2002
Efficacy and safety of the short term immunotherapy (SIT) in allergic rhinoconjunctivitis (AR) Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
Perannual allergic rhinitis (PAR) impairs quality of life (QoL) in patients as assessed by the RFS: French validated generic questionnaire Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Effects of loratadine and its generic on symptoms of asthma and rhinitis Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008